HEADER OXIDOREDUCTASE 15-OCT-09 2WV8 TITLE COMPLEX OF HUMAN DIHYDROOROTATE DEHYDROGENASE WITH THE INHIBITOR TITLE 2 221290 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROOROTATE DEHYDROGENASE, MITOCHONDRIAL; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 31-395; COMPND 5 SYNONYM: DHODEHASE, DIHYDROOROTATE OXIDASE, DHODEHASE; COMPND 6 EC: 1.3.5.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS FLAVOPROTEIN, TRANSMEMBRANE, MITOCHONDRION INNER MEMBRANE, KEYWDS 2 OXIDOREDUCTASE, TRANSIT PEPTIDE, ENZYME INHIBITION, PYRIMIDINE KEYWDS 3 BIOSYNTHESIS, STRUCTURE-BASED DRUG DESIGN, INFLAMATION EXPDTA X-RAY DIFFRACTION AUTHOR B.WALSE,B.SVENSSON,I.FRITZSON,L.DAHLBERG,U.WELLMAR,S.AL-KARADAGHI REVDAT 4 08-MAY-24 2WV8 1 REMARK REVDAT 3 17-JAN-18 2WV8 1 REMARK REVDAT 2 25-APR-12 2WV8 1 JRNL REMARK VERSN REVDAT 1 25-AUG-10 2WV8 0 JRNL AUTH I.FRITZSON,B.SVENSSON,S.AL-KARADAGHI,B.WALSE,U.WELLMAR, JRNL AUTH 2 U.J.NILSSON,D.DA GRACA THRIGE,S.JONSSON JRNL TITL INHIBITION OF HUMAN DHODH BY 4-HYDROXYCOUMARINS, FENAMIC JRNL TITL 2 ACIDS, AND N-(ALKYLCARBONYL)ANTHRANILIC ACIDS IDENTIFIED BY JRNL TITL 3 STRUCTURE-GUIDED FRAGMENT SELECTION. JRNL REF CHEMMEDCHEM V. 5 608 2010 JRNL REFN ISSN 1860-7179 JRNL PMID 20183850 JRNL DOI 10.1002/CMDC.200900454 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2791550.090 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 44920 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2246 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7064 REMARK 3 BIN R VALUE (WORKING SET) : 0.2000 REMARK 3 BIN FREE R VALUE : 0.2390 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 371 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2792 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 348 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.72000 REMARK 3 B22 (A**2) : 0.72000 REMARK 3 B33 (A**2) : -1.44000 REMARK 3 B12 (A**2) : 0.63000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.08 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.13 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.830 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 57.75 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : UNK-ORO.PAR REMARK 3 PARAMETER FILE 4 : FMN.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : FMN.TOP REMARK 3 TOPOLOGY FILE 4 : UNK-ORO.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2WV8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-OCT-09. REMARK 100 THE DEPOSITION ID IS D_1290041387. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.017000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44920 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.26000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.89333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.94667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.94667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 81.89333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2126 O HOH A 2126 4555 1.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 119 N - CA - C ANGL. DEV. = 15.9 DEGREES REMARK 500 SER A 120 N - CA - C ANGL. DEV. = -23.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 41 -61.21 -126.28 REMARK 500 ARG A 72 -65.87 61.29 REMARK 500 ASP A 99 77.94 -113.14 REMARK 500 SER A 120 100.93 143.09 REMARK 500 ARG A 146 49.61 -140.50 REMARK 500 ARG A 146 50.54 -140.50 REMARK 500 THR A 283 108.93 88.24 REMARK 500 TYR A 356 -64.93 -146.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A 398 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ORO A 399 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VGN A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DDQ A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1D3H RELATED DB: PDB REMARK 900 HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH ANTIPROLIFERATIVE REMARK 900 AGENT A771726 REMARK 900 RELATED ID: 2B0M RELATED DB: PDB REMARK 900 HUMAN DIHYDROOROTATE DEHYDROGENASE BOUND TO A NOVELINHIBITOR REMARK 900 RELATED ID: 1D3G RELATED DB: PDB REMARK 900 HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH BREQUINAR ANALOG REMARK 900 RELATED ID: 2BXV RELATED DB: PDB REMARK 900 DUAL BINDING MODE OF A NOVEL SERIES OF DHODH INHIBITORS DBREF 2WV8 A 32 396 UNP Q02127 PYRD_HUMAN 31 395 SEQRES 1 A 365 THR GLY ASP GLU ARG PHE TYR ALA GLU HIS LEU MET PRO SEQRES 2 A 365 THR LEU GLN GLY LEU LEU ASP PRO GLU SER ALA HIS ARG SEQRES 3 A 365 LEU ALA VAL ARG PHE THR SER LEU GLY LEU LEU PRO ARG SEQRES 4 A 365 ALA ARG PHE GLN ASP SER ASP MET LEU GLU VAL ARG VAL SEQRES 5 A 365 LEU GLY HIS LYS PHE ARG ASN PRO VAL GLY ILE ALA ALA SEQRES 6 A 365 GLY PHE ASP LYS HIS GLY GLU ALA VAL ASP GLY LEU TYR SEQRES 7 A 365 LYS MET GLY PHE GLY PHE VAL GLU ILE GLY SER VAL THR SEQRES 8 A 365 PRO LYS PRO GLN GLU GLY ASN PRO ARG PRO ARG VAL PHE SEQRES 9 A 365 ARG LEU PRO GLU ASP GLN ALA VAL ILE ASN ARG TYR GLY SEQRES 10 A 365 PHE ASN SER HIS GLY LEU SER VAL VAL GLU HIS ARG LEU SEQRES 11 A 365 ARG ALA ARG GLN GLN LYS GLN ALA LYS LEU THR GLU ASP SEQRES 12 A 365 GLY LEU PRO LEU GLY VAL ASN LEU GLY LYS ASN LYS THR SEQRES 13 A 365 SER VAL ASP ALA ALA GLU ASP TYR ALA GLU GLY VAL ARG SEQRES 14 A 365 VAL LEU GLY PRO LEU ALA ASP TYR LEU VAL VAL ASN VAL SEQRES 15 A 365 SER SER PRO ASN THR ALA GLY LEU ARG SER LEU GLN GLY SEQRES 16 A 365 LYS ALA GLU LEU ARG ARG LEU LEU THR LYS VAL LEU GLN SEQRES 17 A 365 GLU ARG ASP GLY LEU ARG ARG VAL HIS ARG PRO ALA VAL SEQRES 18 A 365 LEU VAL LYS ILE ALA PRO ASP LEU THR SER GLN ASP LYS SEQRES 19 A 365 GLU ASP ILE ALA SER VAL VAL LYS GLU LEU GLY ILE ASP SEQRES 20 A 365 GLY LEU ILE VAL THR ASN THR THR VAL SER ARG PRO ALA SEQRES 21 A 365 GLY LEU GLN GLY ALA LEU ARG SER GLU THR GLY GLY LEU SEQRES 22 A 365 SER GLY LYS PRO LEU ARG ASP LEU SER THR GLN THR ILE SEQRES 23 A 365 ARG GLU MET TYR ALA LEU THR GLN GLY ARG VAL PRO ILE SEQRES 24 A 365 ILE GLY VAL GLY GLY VAL SER SER GLY GLN ASP ALA LEU SEQRES 25 A 365 GLU LYS ILE ARG ALA GLY ALA SER LEU VAL GLN LEU TYR SEQRES 26 A 365 THR ALA LEU THR PHE TRP GLY PRO PRO VAL VAL GLY LYS SEQRES 27 A 365 VAL LYS ARG GLU LEU GLU ALA LEU LEU LYS GLU GLN GLY SEQRES 28 A 365 PHE GLY GLY VAL THR ASP ALA ILE GLY ALA ASP HIS ARG SEQRES 29 A 365 ARG HET FMN A 398 31 HET ORO A 399 11 HET VGN A 400 25 HET DDQ A 401 14 HET ACT A 402 4 HET SO4 A 403 5 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM ORO OROTIC ACID HETNAM VGN 2-ACETAMIDO-5-(4-PHENYLPHENYL)BENZOIC ACID HETNAM DDQ DECYLAMINE-N,N-DIMETHYL-N-OXIDE HETNAM ACT ACETATE ION HETNAM SO4 SULFATE ION HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 2 FMN C17 H21 N4 O9 P FORMUL 3 ORO C5 H4 N2 O4 FORMUL 4 VGN C21 H17 N O3 FORMUL 5 DDQ C12 H27 N O FORMUL 6 ACT C2 H3 O2 1- FORMUL 7 SO4 O4 S 2- FORMUL 8 HOH *348(H2 O) HELIX 1 1 ASP A 34 HIS A 41 1 8 HELIX 2 2 HIS A 41 LEU A 50 1 10 HELIX 3 3 ASP A 51 LEU A 65 1 15 HELIX 4 4 SER A 76 GLU A 80 5 5 HELIX 5 5 ALA A 104 GLY A 112 1 9 HELIX 6 6 PRO A 138 ASP A 140 5 3 HELIX 7 7 GLY A 153 ALA A 163 1 11 HELIX 8 8 ARG A 164 ASP A 174 1 11 HELIX 9 9 ASP A 190 GLY A 203 1 14 HELIX 10 10 PRO A 204 ALA A 206 5 3 HELIX 11 11 LEU A 221 GLN A 225 5 5 HELIX 12 12 GLY A 226 GLY A 243 1 18 HELIX 13 13 ARG A 245 ARG A 249 5 5 HELIX 14 14 THR A 261 GLY A 276 1 16 HELIX 15 15 LEU A 309 THR A 324 1 16 HELIX 16 16 SER A 338 GLY A 349 1 12 HELIX 17 17 TYR A 356 GLY A 363 1 8 HELIX 18 18 PRO A 364 GLN A 381 1 18 HELIX 19 19 GLY A 385 ILE A 390 1 6 HELIX 20 20 GLY A 391 ARG A 396 5 6 SHEET 1 AA 2 VAL A 81 VAL A 83 0 SHEET 2 AA 2 HIS A 86 PHE A 88 -1 O HIS A 86 N VAL A 83 SHEET 1 AB 9 VAL A 92 ILE A 94 0 SHEET 2 AB 9 LEU A 352 LEU A 355 1 O VAL A 353 N GLY A 93 SHEET 3 AB 9 ILE A 330 VAL A 333 1 O GLY A 332 N GLN A 354 SHEET 4 AB 9 GLY A 279 VAL A 282 1 O LEU A 280 N ILE A 331 SHEET 5 AB 9 ALA A 251 ILE A 256 1 O VAL A 254 N ILE A 281 SHEET 6 AB 9 TYR A 208 ASN A 212 1 O LEU A 209 N LEU A 253 SHEET 7 AB 9 LEU A 178 LEU A 182 1 O VAL A 180 N VAL A 210 SHEET 8 AB 9 PHE A 115 VAL A 121 1 O VAL A 116 N GLY A 179 SHEET 9 AB 9 VAL A 92 ILE A 94 1 O ILE A 94 N GLU A 117 SHEET 1 AC 3 VAL A 134 LEU A 137 0 SHEET 2 AC 3 ALA A 142 ASN A 145 -1 O ALA A 142 N LEU A 137 SHEET 3 AC 3 GLY A 303 GLY A 306 -1 O GLY A 303 N ASN A 145 CISPEP 1 ARG A 131 PRO A 132 0 0.02 SITE 1 AC1 26 ALA A 95 ALA A 96 GLY A 97 LYS A 100 SITE 2 AC1 26 GLY A 119 SER A 120 ASN A 145 TYR A 147 SITE 3 AC1 26 ASN A 181 ASN A 212 LYS A 255 THR A 283 SITE 4 AC1 26 ASN A 284 THR A 285 SER A 305 GLY A 306 SITE 5 AC1 26 LEU A 309 VAL A 333 GLY A 334 GLY A 335 SITE 6 AC1 26 LEU A 355 TYR A 356 THR A 357 ORO A 399 SITE 7 AC1 26 HOH A2344 HOH A2345 SITE 1 AC2 11 LYS A 100 ASN A 145 TYR A 147 GLY A 148 SITE 2 AC2 11 PHE A 149 ASN A 212 SER A 215 ASN A 217 SITE 3 AC2 11 ASN A 284 THR A 285 FMN A 398 SITE 1 AC3 15 TYR A 38 LEU A 46 GLN A 47 PRO A 52 SITE 2 AC3 15 ALA A 55 HIS A 56 ALA A 59 LEU A 67 SITE 3 AC3 15 LEU A 68 VAL A 134 ARG A 136 TYR A 356 SITE 4 AC3 15 THR A 360 PRO A 364 HOH A2310 SITE 1 AC4 3 LEU A 58 PHE A 62 LEU A 68 SITE 1 AC5 7 LYS A 307 PRO A 308 ASP A 311 THR A 314 SITE 2 AC5 7 GLN A 315 ARG A 318 HOH A2346 SITE 1 AC6 4 ARG A 245 HIS A 248 HOH A2347 HOH A2348 CRYST1 90.660 90.660 122.840 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011030 0.006368 0.000000 0.00000 SCALE2 0.000000 0.012737 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008141 0.00000